[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
News From the Centers for Disease Control and Prevention
December 19, 2001

Update: Investigation of Bioterrorism-Related Inhalation Anthrax—Connecticut, 2001

JAMA. 2001;286(23):2936-2937. doi:10.1001/jama.286.23.2936-JWR1219-2-1

MMWR. 2001;50:1029-31

Since October 3, 2001, CDC and state and local public health authorities have been investigating cases of bioterrorism-related anthrax.1-5 As of November 28, a total of 23 cases have been identified; 11 were confirmed as inhalational anthrax, and 12 (seven confirmed and five suspected) were cutaneous. Epidemiologic investigations to identify the source of exposure to Bacillus anthracis continue for a case of inhalational anthrax in a hospital stockroom worker in New York City (NYC) and, most recently, a case of inhalational anthrax in an elderly woman in Connecticut (CT). Antimicrobial prophylaxis is continuing in persons exposed to B. anthracis, and surveillance to detect new cases of bioterrorism-related anthrax is ongoing. This report summarizes the findings of the case investigation in CT.